StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
BioLife Solutions, Inc.
NasdaqCM:BLFS
Sector
Industries
Location
Market Cap
USD 1.07 B
Share Price
USD 22.33
Avg Daily Volume
604,801
Change (1 day)
-0.98%
Change (1 year)
16.36%
Change (YTD)
-13.98%
BioLife Solutions, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -17.56%
BioLife Solutions, Inc. EBITDA Margin is -17.56% for the Trailing 12 Months (TTM) ending September 30, 2024, a -43.23% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
BioLife Solutions, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -30.93%, a -48.26% change year over year.
-
BioLife Solutions, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -59.79%, a 261.87% change year over year.
-
BioLife Solutions, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -16.52%, a -37.57% change year over year.
-
BioLife Solutions, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was -26.47%, a -330.11% change year over year.
Competitors
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Novo Nordisk A/S
USD 69.43
NOVO-B.CO
-1.17
-1.65%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
Novartis AG
USD 122.69
NOVN.SW
+0.12
0.10%
Abbott Laboratories
USD 133.22
ABT
-0.14
-0.10%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Thermo Fisher Scientific Inc.
USD 419.88
TMO
-6.29
-1.48%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Boston Scientific Corporation
USD 102.96
BSX
+0.55
0.54%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Danaher Corporation
USD 200.96
DHR
+0.28
0.14%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Vertex Pharmaceuticals Incorporated
USD 478.96
VRTX
+12.60
2.70%
Bristol-Myers Squibb Company
USD 47.66
BMY
+0.62
1.32%
GSK plc
USD 19.36
GSK.L
+0.16
0.81%
CSL Limited
USD 159.25
CSL.AX
-1.34
-0.84%
Chugai Pharmaceutical Co., Ltd.
USD 46.51
4519.T
-0.57
-1.20%
Zoetis Inc.
USD 158.27
ZTS
+0.47
0.30%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Novo Nordisk A/S
USD 69.43
NOVO-B.CO
-1.17
-1.65%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
Novartis AG
USD 122.69
NOVN.SW
+0.12
0.10%
Abbott Laboratories
USD 133.22
ABT
-0.14
-0.10%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Thermo Fisher Scientific Inc.
USD 419.88
TMO
-6.29
-1.48%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Boston Scientific Corporation
USD 102.96
BSX
+0.55
0.54%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Danaher Corporation
USD 200.96
DHR
+0.28
0.14%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Vertex Pharmaceuticals Incorporated
USD 478.96
VRTX
+12.60
2.70%
Bristol-Myers Squibb Company
USD 47.66
BMY
+0.62
1.32%
GSK plc
USD 19.36
GSK.L
+0.16
0.81%
CSL Limited
USD 159.25
CSL.AX
-1.34
-0.84%
Chugai Pharmaceutical Co., Ltd.
USD 46.51
4519.T
-0.57
-1.20%
Zoetis Inc.
USD 158.27
ZTS
+0.47
0.30%